Acute severe cutaneous methotrexate toxicity in a patient with rheumatoid arthritis: Report of a rare side effect
Conclusion: Although MTX is an option of great therapeutic value for RA. Rheumatologists and Dermatologists need to be alert to the possibility of cutaneous adverse events associated with MTX therapy.
Source: The Egyptian Rheumatologist - Category: Rheumatology Source Type: research
More News: Actemra | Arthritis | Corticosteroid Therapy | Dermatology | Egypt Health | Gastroenterology | Methotrexate | Prednisone | Psoriasis | Rheumatoid Arthritis | Rheumatology | Skin | Skin Biopsy | Study | Toxicology | Tunisia Health